Sylogist Ltd.
SYZLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $208 | $175 | $149 | $248 |
| - Cash | $13 | $12 | $15 | $30 |
| + Debt | $19 | $18 | $22 | $19 |
| Enterprise Value | $214 | $181 | $156 | $237 |
| Revenue | $66 | $66 | $69 | $39 |
| % Growth | 0.1% | -5.1% | 78.4% | – |
| Gross Profit | $39 | $29 | $31 | $28 |
| % Margin | 58.8% | 44.9% | 44.4% | 72.3% |
| EBITDA | $8 | $11 | $15 | $15 |
| % Margin | 11.7% | 16.9% | 22.3% | 37.5% |
| Net Income | -$1 | $1 | $3 | $4 |
| % Margin | -1.1% | 1.7% | 3.7% | 11.3% |
| EPS Diluted | -0.031 | 0.047 | 0.11 | 0.18 |
| % Growth | -166.9% | -57.7% | -38.9% | – |
| Operating Cash Flow | $12 | $10 | $13 | $19 |
| Capital Expenditures | -$0 | -$5 | -$3 | -$1 |
| Free Cash Flow | $12 | $5 | $9 | $18 |